RE:RE:La Presse article MrMugsy wrote:
Good little chat - more of a review of where we've been.
Most recent numbers came from Samira - 700 employees in LATAM and 40 in Canada.
Roughtly 740 employees in early January 2022.
Let's see what happens to that number by yearend.
Thanks for the link.
Nice to see Samira interviewed even though it would have been even nicer to get a longer / more in-depth interview.
I wonder if this is translated correctly:
Q. I noticed that some company insiders, including the founder, Jonathan Goodman, and you, have made several purchases of stock lots recently. Is Knight Therapeutics' share price an issue for you?
A. Yes, absolutely, it is a significant pressure, especially for more than a year when the value of the stock has remained around $5. Three years ago, when we had only money and very little income, the stock was trading at over $10.
Why would the stock price be "an issue" and "a significant pressure" for Samira/GUD? I mean, as long as the business keeps improving...